HCW Biologics (HCWB) FCF Margin (2022 - 2025)
HCW Biologics' (HCWB) quarterly FCF Margin came in at 12423.24% in Q4 2025, down 1167992.0% on a YoY basis from N/an in Q4 2024, and up 40.16% quarter-over-quarter from 20760.87% in Q3 2025.
Powered by 
Analysis
HCW Biologics (HCWB) FCF Margin (2022 - 2025) Analysis & Trends
HCW Biologics (HCWB) has reported FCF Margin for 4 consecutive years, with 12423.24% the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, FCF Margin fell 1167992.0% year-over-year to 12423.24%; the trailing twelve-month figure through Dec 2025 stood at 24693.66% (down 2406104.0% YoY), and the FY2025 full-year result was 24693.2%, down 2406059.0% from the prior year.
- FCF Margin improved to 12423.24% in Q4 2025 per HCWB's latest filing, from 20760.87% in the prior quarter.
- Across five years, FCF Margin topped out at 51.83% in Q1 2022 and bottomed at 69375.24% in Q1 2025.
- Historically, FCF Margin has averaged 10590.99% across 4 years, with a median of 724.2% in 2023.
- The sharpest annual moves came in 2024 and 2025: FCF Margin surged 888938 bps in 2024, then sank 6886081 bps in 2025.
- Over 4 years, FCF Margin stood at 287.59% in 2022, then plunged by 100 bps to 574.81% in 2023, then declined by 29 bps to 743.32% in 2024, then sank by 1571 bps to 12423.24% in 2025.
- According to Business Quant data, FCF Margin over the past three periods registered 12423.24%, 20760.87%, and 50111.5% for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.38 Bn | 192.39 Bn | 7.24 Bn | 34.70% |
| 2 | Gilead Sciences | 180.22 Bn | 177.04 Bn | 6.22 Bn | 44.00% |
| 3 | Vertex Pharmaceuticals | 131.28 Bn | 123.42 Bn | 2.84 Bn | 30.39% |
| 4 | Regeneron Pharmaceuticals | 81.96 Bn | 73.97 Bn | 3.93 Bn | 13.35% |
| 5 | Argenx Se | 60.49 Bn | 55.30 Bn | 1.37 Bn | - |
| 6 | Moderna | 53.90 Bn | 48.76 Bn | 52.00 Mn | -388.28% |
| 7 | Alnylam Pharmaceuticals | 33.41 Bn | 30.11 Bn | 992.69 Mn | 22.62% |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn | 14.91% |
| 9 | Roivant Sciences | 29.08 Bn | 29.08 Bn | 1.16 Mn | -18,629.40% |
| 10 | HCW Biologics | 3.24 Mn | 2.50 Mn | -93,887.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -12,423.24% |
| Sep 30, 2025 | -20,760.87% |
| Jun 30, 2025 | -50,111.50% |
| Mar 31, 2025 | -69,375.24% |
| Dec 31, 2024 | -743.32% |
| Sep 30, 2024 | -719.37% |
| Jun 30, 2024 | -717.39% |
| Mar 31, 2024 | -514.43% |
| Dec 31, 2023 | -574.81% |
| Sep 30, 2023 | -729.02% |
| Jun 30, 2023 | -1,757.91% |
| Mar 31, 2023 | -9,403.81% |
| Dec 31, 2022 | -287.59% |
| Sep 30, 2022 | -690.14% |
| Jun 30, 2022 | -595.32% |
| Mar 31, 2022 | -51.83% |